PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32649737-3	2020	In this study, we investigated the effects of AKT-mediated miR-125b-5p alteration on metabolic changes and examined how these molecules enhance migration and induce drug resistance in colon cancer cells.	mir-125b-5p	59-70	AKT serine/threonine kinase 1	Homo sapiens	46-49	
34149884-0	2021	miR-125b-5p inhibits cell proliferation by targeting ASCT2 and regulating the PI3K/AKT/mTOR pathway in an LPS-induced intestinal mucosa cell injury model.	mir-125b-5p	0-11	AKT serine/threonine kinase 1	Homo sapiens	83-86	
34149884-14	2021	Transfection with the miR-125b-5p mimic also exhibited a suppressive effect on the PI3K/AKT/mTOR pathway in the LPS-induced intestinal mucosal cell injury model.	mir-125b-5p	22-33	AKT serine/threonine kinase 1	Homo sapiens	88-91	
34149884-15	2021	Overall, the present study indicated that miR-125b-5p accelerated LPS-induced intestinal mucosa cell injury by targeting ASCT2 and upregulating the PI3K/AKT/mTOR pathway.	mir-125b-5p	42-53	AKT serine/threonine kinase 1	Homo sapiens	153-156	
31518563-11	2019	Akt/mTOR signaling was involved in miR-125b-5p mimics- or miR-181b-5p mimics-mediated inhibition effect on HEKs proliferation.	mir-125b-5p	35-46	AKT serine/threonine kinase 1	Homo sapiens	0-3